Confocal laser endomicroscopy as predictive biomarker of clinical and endoscopic efficacy of vedolizumab in ulcerative colitis: The DETECT study.

Confocal laser endomicroscopy as predictive biomarker of clinical and endoscopic efficacy of vedolizumab in ulcerative colitis: The DETECT study.

Show other versions (1)

<h4>Aims</h4>In patients with ulcerative colitis (UC), no biomarker is available to help the physician to choose the most suitable biotherapy. The primary objective of this pilot study was to assess the feasibility of identification of α4β7- and TNF-expressing cells, to predict the respo...

Full description

Bibliographic Details
Main Authors: Lucille Quénéhervé, Caroline Trang-Poisson, Aurélie Fantou, Mathurin Flamant, Tony Durand, Guillaume Bouguen, Jérémy Bregeon, Thibauld Oullier, Morgane Amil, Marie Dewitte, Stéphanie Bardot, Stéphanie Blandin, Cécile Braudeau, Marie-Anne Vibet, Régis Josien, Michel Neunlist, Arnaud Bourreille
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0298313

Internet

https://doi.org/10.1371/journal.pone.0298313

Similar Items